Clinical implication of circulating tumor cells expressing epithelial mesenchymal transition (EMT) and cancer stem cell (CSC) markers and their perspective in HCC: a …

S Orrapin, S Udomruk, W Lapisatepun, S Moonmuang… - cancers, 2022 - mdpi.com
Simple Summary One of the major problems regarding hepatocellular carcinoma (HCC) is
the development of metastasis and recurrence, even in patients with an early stage …

Tumor burden score and serum alpha-fetoprotein subclassify intermediate-stage hepatocellular carcinoma

HA Lima, Y Endo, L Alaimo, Z Moazzam… - Journal of …, 2022 - Elsevier
Abstract Background Resection of Barcelona Clinic Liver Cancer (BCLC) intermediate-stage
hepatocellular carcinoma (HCC) remains controversial. While not recommended by the …

TBS-based preoperative score to predict non-transplantable recurrence and identify candidates for upfront resection versus transplantation for hepatocellular …

HA Lima, Z Moazzam, Y Endo, L Alaimo… - Annals of Surgical …, 2023 - Springer
Background Recurrence following liver resection (LR) for hepatocellular carcinoma (HCC)
can be as high as 50–70%. While salvage liver transplantation may be feasible, patients …

[HTML][HTML] Prognostic significance of long noncoding RNA HOTAIR in hepatocellular carcinoma: a protocol for systematic review and meta-analysis

L Feng, W Liu, Y Lv, B Qiao - Medicine, 2022 - journals.lww.com
Background: Homeobox transcript antisense intergenic RNA (HOTAIR), a long noncoding
RNA, has been reported to associate with the prognosis of patients with hepatocellular …

TAC score better predicts survival than the BCLC following resection of hepatocellular carcinoma

HA Lima, Y Endo, Z Moazzam, L Alaimo… - Journal of surgical …, 2023 - Wiley Online Library
Background Heterogeneity in hepatocellular carcinoma (HCC) still exists within the
Barcelona clinic liver cancer (BCLC) subcategories. We developed a simple model to better …

Effects of Curative-Intent Treatments on Hepatocellular Carcinoma Survival in Alcohol-Related Cirrhosis: A Nationwide Study

F Kraglund, GE Villadsen, P Jepsen - Clinical Epidemiology, 2023 - Taylor & Francis
Purpose The aim of curative-intent treatment for hepatocellular carcinoma (HCC) is to
restore the patients' survival to what it would have been, had they not developed HCC. We …

[HTML][HTML] 影响肝细胞癌切除术后复发和预后因素的研究进展

刘南秋, 龚建平 - Advances in Clinical Medicine, 2022 - hanspub.org
肝细胞癌是全球癌症死亡率第三的癌症. 肝切除术是治疗肝细胞癌的主要治疗方式,
但术后的高复发率严重影响了患者预后. 肝细胞癌肝切除术后的复发和预后受多种因素影响 …

[PDF][PDF] Assessment of Serum Cytokine Levels in Patients with Hepatocellular Carcinoma and those with Chronic Liver Disease: Cross-Sectional Study

DS Mbaga, JN Bikoï, EA Okobalemba… - American Journal of …, 2023 - researchgate.net
The diagnosis of hepatocellular carcinoma (HCC) is currently limited by the use of Alpha-
fetoprotein (AFP) levels and medical imaging. To improve the diagnostic process, this study …